(Total Views: 339)
Posted On: 12/02/2019 5:50:03 PM
Post# of 154185
I have previously researched that vaccine some. The crazy thing is I can't even find animal study data results, no phase 1 results, no phase 2 results. Who knows if they will do better this time than the 30% they got like last time.
It is only for subtype C, which is the most common, but less than 5% in the US and Europe. So they have a long way to go.
Quote:
The experimental vaccine regimen tested in the Thai trial was found to be 31.2 percent effective at preventing HIV infection over the 3.5-year follow-up after vaccination. In the HVTN 702 study, the design, schedule and components of the RV144 vaccine regimen have been modified in an attempt to increase the magnitude and duration of vaccine-elicited protective immune responses.
It is only for subtype C, which is the most common, but less than 5% in the US and Europe. So they have a long way to go.
Quote:
HVTN 702 is testing vaccines similar to those used in RV 144 but adapted for the subtype of HIV common to the region where most new HIV infections occur, sub-Saharan Africa
(1)
(0)
